Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
6
×
Tags
biotech
6
×
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
glaxosmithkline
6
×
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
6
×
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
6
×
seattle blog main
seattle top stories
startups
6
×
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
clinical trials
alzheimer's disease
amgen
cancer
cancer immunotherapy
deals
eli lilly
fda
merck
abbvie
biogen
What
roundup
bio
black
companies
crispr
diamond’s
drug
nash
news
according
acquisitions
akcea
albert
alliance
appetite
approval
biggest
biogen’s
biopharmaceutical
biotech
bourla
bread
bristol
butter
buy
buyout
calls
cancer
cases
cash
centers
ceo
changing
cigarettes
color
company
continue
control
convo
days
Language
unset
unknown
Current search:
glaxosmithkline
×
startups
×
biotech
×
photo
×
" new york top stories "
×
" san francisco top stories "
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
4 years ago
Biotech Roundup: Vaping Toll Rises, NASH News, Akcea Shakeup & More
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More